About
Synolo Therapeutics develops RNA-targeted therapies aimed at treating neurodegenerative diseases.
Explore Synolo Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Synolo Therapeutics develops RNA-targeted therapies aimed at treating neurodegenerative diseases.
Funding rounds, investor list, and risk signals — unlock with a subscription.